ID

14381

Description

Inhaler Adherence in Poorly Controlled Asthma; ODM derived from: https://clinicaltrials.gov/show/NCT02307669

Lien

https://clinicaltrials.gov/show/NCT02307669

Mots-clés

Versions (1)
  1. 12/04/2016 12/04/2016 -
Téléchargé le

12 avril 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Asthma NCT02307669

Anglais

Eligibility Asthma NCT02307669

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02307669
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
must be willing to give voluntary informed consent
Description

Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0021430
must have a clinical diagnosis of asthma-
Description

Asthma

Type de données

boolean

Alias
UMLS CUI [1]
C0004096
must have a bronchodilator fev1 > 40% and <80% in the past 1 year
Description

FEV1 Bronchodilator Agents

Type de données

boolean

Alias
UMLS CUI [1,1]
C0748133
UMLS CUI [1,2]
C0006280
current unstable asthma i.e. act score is less than 19 at enrolment.
Description

Unstable status Asthma | Asthma control test score

Type de données

boolean

Alias
UMLS CUI [1,1]
C0443343
UMLS CUI [1,2]
C0004096
UMLS CUI [2]
C2733224
two or more courses of oral corticosteroids in the prior year, or a hospitalization or ed attendance with an asthma exacerbation in the last year
Description

Adrenal Cortex Hormones | Hospitalization | Emergency room admission Exacerbation of asthma

Type de données

boolean

Alias
UMLS CUI [1]
C0001617
UMLS CUI [2]
C0019993
UMLS CUI [3,1]
C0583237
UMLS CUI [3,2]
C0349790
age 18 years or older at time of consent.
Description

Age | Informed Consent

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2]
C0021430
capable of understanding and complying with the requirements of the protocol, including ability to attend for all required visits.
Description

Compliance behavior Comprehension

Type de données

boolean

Alias
UMLS CUI [1,1]
C1321605
UMLS CUI [1,2]
C0162340
able and willing to take inhaled medication via a diskus.
Description

Ability Take Inhalation preparations Diskus

Type de données

boolean

Alias
UMLS CUI [1,1]
C0085732
UMLS CUI [1,2]
C1515187
UMLS CUI [1,3]
C0354922
UMLS CUI [1,4]
C1553480
in the opinion of the investigator suitable for use of a salmeterol/fluticasone diskus inhaler or already using a salmeterol/fluticasone inhaler.
Description

Use of salmeterol Inhaler | Use of fluticasone Inhaler | Diskus

Type de données

boolean

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C0073992
UMLS CUI [1,3]
C0021461
UMLS CUI [2,1]
C1524063
UMLS CUI [2,2]
C0082607
UMLS CUI [2,3]
C0021461
UMLS CUI [3]
C1553480
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
have used any investigational product or device within 3 months of the enrolment visit.
Description

Use of Investigational product | Use of Investigational Medical Device

Type de données

boolean

Alias
UMLS CUI [1,1]
C1524063
UMLS CUI [1,2]
C1517586
UMLS CUI [1,3]
C1514468
UMLS CUI [2,1]
C1524063
UMLS CUI [2,2]
C2346570
have known previous sensitivity to seretide.
Description

Hypersensitivity Seretide

Type de données

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C1130494
have a known significant (in the opinion of the investigator) concurrent medical disease that might mean that the participant cannot complete the year long observation study.
Description

Comorbidity Study Subject Participation Status Limited

Type de données

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C0439801
Retour au début de la page

Similar models

Eligibility Asthma NCT02307669

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Asthma NCT02307669
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Informed Consent
Item
must be willing to give voluntary informed consent
boolean
C0021430 (UMLS CUI [1])
Asthma
Item
must have a clinical diagnosis of asthma-
boolean
C0004096 (UMLS CUI [1])
FEV1 Bronchodilator Agents
Item
must have a bronchodilator fev1 > 40% and <80% in the past 1 year
boolean
C0748133 (UMLS CUI [1,1])
C0006280 (UMLS CUI [1,2])
Unstable status Asthma | Asthma control test score
Item
current unstable asthma i.e. act score is less than 19 at enrolment.
boolean
C0443343 (UMLS CUI [1,1])
C0004096 (UMLS CUI [1,2])
C2733224 (UMLS CUI [2])
Adrenal Cortex Hormones | Hospitalization | Emergency room admission Exacerbation of asthma
Item
two or more courses of oral corticosteroids in the prior year, or a hospitalization or ed attendance with an asthma exacerbation in the last year
boolean
C0001617 (UMLS CUI [1])
C0019993 (UMLS CUI [2])
C0583237 (UMLS CUI [3,1])
C0349790 (UMLS CUI [3,2])
Age | Informed Consent
Item
age 18 years or older at time of consent.
boolean
C0001779 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Compliance behavior Comprehension
Item
capable of understanding and complying with the requirements of the protocol, including ability to attend for all required visits.
boolean
C1321605 (UMLS CUI [1,1])
C0162340 (UMLS CUI [1,2])
Ability Take Inhalation preparations Diskus
Item
able and willing to take inhaled medication via a diskus.
boolean
C0085732 (UMLS CUI [1,1])
C1515187 (UMLS CUI [1,2])
C0354922 (UMLS CUI [1,3])
C1553480 (UMLS CUI [1,4])
Use of salmeterol Inhaler | Use of fluticasone Inhaler | Diskus
Item
in the opinion of the investigator suitable for use of a salmeterol/fluticasone diskus inhaler or already using a salmeterol/fluticasone inhaler.
boolean
C1524063 (UMLS CUI [1,1])
C0073992 (UMLS CUI [1,2])
C0021461 (UMLS CUI [1,3])
C1524063 (UMLS CUI [2,1])
C0082607 (UMLS CUI [2,2])
C0021461 (UMLS CUI [2,3])
C1553480 (UMLS CUI [3])
Item Group
C0680251 (UMLS CUI)
Use of Investigational product | Use of Investigational Medical Device
Item
have used any investigational product or device within 3 months of the enrolment visit.
boolean
C1524063 (UMLS CUI [1,1])
C1517586 (UMLS CUI [1,2])
C1514468 (UMLS CUI [1,3])
C1524063 (UMLS CUI [2,1])
C2346570 (UMLS CUI [2,2])
Hypersensitivity Seretide
Item
have known previous sensitivity to seretide.
boolean
C0020517 (UMLS CUI [1,1])
C1130494 (UMLS CUI [1,2])
Comorbidity Study Subject Participation Status Limited
Item
have a known significant (in the opinion of the investigator) concurrent medical disease that might mean that the participant cannot complete the year long observation study.
boolean
C0009488 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C0439801 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial